Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment
1. A recently recognized complication of uncontrolled diabetes mellitus is the encephalopathy involving, among other regions, the hippocampus. Since estrogens bring neuroprotection in cases of brain injury and degenerative diseases, we have studied if estradiol (E2) administration counteracts some h...
Guardado en:
| Publicado: |
2006
|
|---|---|
| Materias: | |
| Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02724340_v26_n4-6_p943_Saravia http://hdl.handle.net/20.500.12110/paper_02724340_v26_n4-6_p943_Saravia |
| Aporte de: |
| id |
paper:paper_02724340_v26_n4-6_p943_Saravia |
|---|---|
| record_format |
dspace |
| spelling |
paper:paper_02724340_v26_n4-6_p943_Saravia2023-06-08T15:25:05Z Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment Apolipoprotein E Astrocytosis Diabetes mellitus Estrogens Hippocampus Neurogenesis apolipoprotein E estradiol glial fibrillary acidic protein animal article astrocyte C57BL mouse cell proliferation comparative study diabetic neuropathy drug effect evaluation experimental diabetes mellitus hippocampus male metabolism mouse pathology Animals Apolipoproteins E Astrocytes Cell Proliferation Diabetes Mellitus, Experimental Diabetic Neuropathies Estradiol Glial Fibrillary Acidic Protein Hippocampus Male Mice Mice, Inbred C57BL 1. A recently recognized complication of uncontrolled diabetes mellitus is the encephalopathy involving, among other regions, the hippocampus. Since estrogens bring neuroprotection in cases of brain injury and degenerative diseases, we have studied if estradiol (E2) administration counteracts some hippocampal abnormalities of streptozotocin (STZ)-diabetic adult mice. 2. We first report the ability of E2 to modulate neurogenesis in the dentate gyrus (DG) and subventricular zone (SVZ) of diabetic mice. Using bromodeoxyuridine (BrdU) to label newly generated cells, a strong reduction in cell proliferation was obtained in DG and SVZ of mice sacrificed 20 days after STZ administration. The reduction was completely relieved by 10 days of E2 pellet implantation, which increased 30-fold the circulating E2 levels. 3. Diabetic mice also showed abnormal expression of astrocyte markers in hippocampus. Thus, increased number of GFAP+ cells, indicative of astrogliosis, and increased number of apolipoprotein-E (Apo-E)+ astrocytes, a marker of ongoing neuronal dysfunction, was found in stratum radiatum below the CA1 hippocampal subfield of diabetic mice. Both parameters were reverted to normal by the E2 regime that upregulated cell proliferation. 4. The studies demonstrated that hippocampal neuropathology of uncontrolled diabetes is a reversible condition and sensitive to estrogen treatment. Studies in animal models may open up new venues for understanding the beneficial role of steroid hormones in diabetic encephalopathy. © 2006 Springer Science+Business Media, Inc. 2006 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02724340_v26_n4-6_p943_Saravia http://hdl.handle.net/20.500.12110/paper_02724340_v26_n4-6_p943_Saravia |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
Apolipoprotein E Astrocytosis Diabetes mellitus Estrogens Hippocampus Neurogenesis apolipoprotein E estradiol glial fibrillary acidic protein animal article astrocyte C57BL mouse cell proliferation comparative study diabetic neuropathy drug effect evaluation experimental diabetes mellitus hippocampus male metabolism mouse pathology Animals Apolipoproteins E Astrocytes Cell Proliferation Diabetes Mellitus, Experimental Diabetic Neuropathies Estradiol Glial Fibrillary Acidic Protein Hippocampus Male Mice Mice, Inbred C57BL |
| spellingShingle |
Apolipoprotein E Astrocytosis Diabetes mellitus Estrogens Hippocampus Neurogenesis apolipoprotein E estradiol glial fibrillary acidic protein animal article astrocyte C57BL mouse cell proliferation comparative study diabetic neuropathy drug effect evaluation experimental diabetes mellitus hippocampus male metabolism mouse pathology Animals Apolipoproteins E Astrocytes Cell Proliferation Diabetes Mellitus, Experimental Diabetic Neuropathies Estradiol Glial Fibrillary Acidic Protein Hippocampus Male Mice Mice, Inbred C57BL Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| topic_facet |
Apolipoprotein E Astrocytosis Diabetes mellitus Estrogens Hippocampus Neurogenesis apolipoprotein E estradiol glial fibrillary acidic protein animal article astrocyte C57BL mouse cell proliferation comparative study diabetic neuropathy drug effect evaluation experimental diabetes mellitus hippocampus male metabolism mouse pathology Animals Apolipoproteins E Astrocytes Cell Proliferation Diabetes Mellitus, Experimental Diabetic Neuropathies Estradiol Glial Fibrillary Acidic Protein Hippocampus Male Mice Mice, Inbred C57BL |
| description |
1. A recently recognized complication of uncontrolled diabetes mellitus is the encephalopathy involving, among other regions, the hippocampus. Since estrogens bring neuroprotection in cases of brain injury and degenerative diseases, we have studied if estradiol (E2) administration counteracts some hippocampal abnormalities of streptozotocin (STZ)-diabetic adult mice. 2. We first report the ability of E2 to modulate neurogenesis in the dentate gyrus (DG) and subventricular zone (SVZ) of diabetic mice. Using bromodeoxyuridine (BrdU) to label newly generated cells, a strong reduction in cell proliferation was obtained in DG and SVZ of mice sacrificed 20 days after STZ administration. The reduction was completely relieved by 10 days of E2 pellet implantation, which increased 30-fold the circulating E2 levels. 3. Diabetic mice also showed abnormal expression of astrocyte markers in hippocampus. Thus, increased number of GFAP+ cells, indicative of astrogliosis, and increased number of apolipoprotein-E (Apo-E)+ astrocytes, a marker of ongoing neuronal dysfunction, was found in stratum radiatum below the CA1 hippocampal subfield of diabetic mice. Both parameters were reverted to normal by the E2 regime that upregulated cell proliferation. 4. The studies demonstrated that hippocampal neuropathology of uncontrolled diabetes is a reversible condition and sensitive to estrogen treatment. Studies in animal models may open up new venues for understanding the beneficial role of steroid hormones in diabetic encephalopathy. © 2006 Springer Science+Business Media, Inc. |
| title |
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| title_short |
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| title_full |
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| title_fullStr |
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| title_full_unstemmed |
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| title_sort |
hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| publishDate |
2006 |
| url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02724340_v26_n4-6_p943_Saravia http://hdl.handle.net/20.500.12110/paper_02724340_v26_n4-6_p943_Saravia |
| _version_ |
1768545645476446208 |